Trial Profile
A Study to Evaluate the Effectiveness of Vismodegib in Management of Basal Cell Carcinoma With Orbital Extension and/or Extensive Periocular Involvement
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Jun 2016 New trial record